Introduction Harold H. Shlevin, PhD; President and Chief Executive Officer, Tikvah Therapeutics, Inc.

State of the Life Sciences Industry in Georgia Russell M. Medford, MD, PhD; President and Chief Executive Officer, AtheroGenics, Inc. and Chairman, Georgia Bio

Elements for Success for Emerging Medical Device Companies Howard D. Palefsky; General Partner/Managing Member, Montreux Equity Partners

1a. The Next Wave of Innovation in Agricultural Sciences Stephen R. Padgette, PhD; Vice President Biotechnology, Monsanto Corporation Edwin Quattlebaum, PhD; Co-Chairman, President and Chief Executive Officer, MetaMorphix, Inc.

1b. Georgia is the Epicenter of Global Healthcare Vincent C. Bond, PhD; Associate Professor and HIV-AIDS Researcher, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine Daniel G. Colley, PhD; Director, Center for Tropical and Emerging Global Diseases, Professor of Microbiology, The University of Georgia Ernesto Ruiz-Tiben, PhD; Director, Dracunculiasis (Guinea worm disease) Eradication Program, The Carter Center

1c. The Next Generation of Georgia's Life Science Companies Russell H. Plumb; President and Chief Executive Officer, Inhibitex, Inc.

2a. Medical Device Innovation in Georgia Lawrence Catchpole; President and Chief Executive Officer, Detect Bruce W. Smith; Executive Vice President Strategy and Business Development, Theragenics Corporation

Research Advances in Georgia: Focus on Cancer Margaret K. Offermann, MD, PhD - Moderator; Deputy National Vice President for Research, American Cancer Society Brian Leyland-Jones, MD, PhD; Georgia Research Alliance Eminent Scholar and Director, Winship Cancer Institute, Emory University

ViraTag LLC